IGEA Pharma N.V is a biopharmaceutical company focused on biomedical solutions for the prevention of diabetes and alzheimer’s disease.
Location: Switzerland
Investors 1
| Date | Name | Website |
| - | LDA Capita... | ldacap.com |
Mentions in press and media 7
| Date | Title | Description |
| 26.11.2021 | IGEA Pharma N : GBC AG Publishes initial equity research report with buy recommendation and price target of EUR 1.05 | GBC AG Publishes initial equity research report with buy recommendation and price target of EUR 1.05 25 November 2021 Categories: Ad hoc announcement pursuant to article 53 LR, Press releases/News Hoofddorp, the Netherlands, 25 November 202... |
| 10.07.2021 | EQS-Adhoc : IGEA ANNOUNCES ANNUAL GENERAL MEETING RESOLUTIONS | EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Miscellaneous IGEA ANNOUNCES ANNUAL GENERAL MEETING RESOLUTIONS 10-Jul-2021 / 01:02 CET/CEST Release of an ad hoc announcement pursuant to Art. 18 LR The issuer is solely responsible for the... |
| 01.07.2021 | IGEA Pharma N : TO LAUNCH THE ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD. | EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Miscellaneous IGEA TO LAUNCH THE ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD. 01-Jul-2021 / 11:11 CET/CEST Release of an ad hoc announcement pursuant to Art. 18 LR The issuer is solel... |
| 03.06.2021 | IGEA PHARMA N.V. IGEA Pharma N : announces changes in its board and other corporate updates | Hoofddorp, the Netherlands, 3June 2021. IGEA Pharma N.V. (SIX: IGPH) today announced the resignation of Mrs. Rosanna Squitti and Mr. Giovanni Ferrario from its board of directors. Mr. Ferrario resigned for personal reasons and Mrs. Squitti ... |
| 01.06.2021 | IGEA PHARMA N.V. IGEA Pharma: Annual report | IGEA Pharma N.V. Annual report 2020 Table of content Section I - Management review 2020………………………………………………………………………….………….. 3 Section II - Corporate Governance Report …………………………………………………………….……….….…… 5 Section III - Consolidated Financial St... |
| 28.04.2021 | IGEA PHARMA N.V. IGEA Pharma N : announces extraordinary general meeting results | Hoofddorp, the Netherlands, 28 April 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that the extraordinary general meeting unanimously approved all the Board of directors' proposals. The minutes of the meeting is available at https://ww... |
| 28.04.2021 | IGEA PHARMA N.V. IGEA Pharma N : announces extraordinary general meeting results | EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Miscellaneous IGEA announces extraordinary general meeting results 28-Apr-2021 / 21:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 18 KR The issuer is solely responsible for ... |